DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000MG4CYM0

Real-time Bid/Ask 08:50:51 2024-06-24 EDT
0.181 EUR / 0.203 EUR +0.52% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month-42.12%
1 month-57.56%
Date Price Change
24-06-24 0.195 +2.09%
24-06-21 0.191 +3.24%
24-06-20 0.185 -4.15%
24-06-18 0.193 +15.57%
24-06-17 0.167 -5.11%

Delayed Quote Börse Stuttgart

Last update June 24, 2024 at 04:48 am

More quotes

Static data

Product typeWarrant Esotici e Strutturati
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4CYM
ISINDE000MG4CYM0
Date issued 2024-05-16
Strike 92.5 $
Maturity 2025-03-21 (270 Days)
Parity 10 : 1
Emission price 0.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.47
Lowest since issue 0.156
Spread 0.008
Spread %4.02%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
62.48 USD
Average target price
86.09 USD
Spread / Average Target
+37.78%
Consensus